Duquesne Family Office LLC / SRPT
Duquesne Family Office LLC’s Sarepta Therapeutics Inc Position
Does Duquesne Family Office LLC own Sarepta Therapeutics Inc (SRPT)? Not currently — the last reported position was 169.3K shares worth $27M in Q2 2020; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$27M
Q2 2020
Shares
169.3K
% of Portfolio
+0.83%
Quarters Held
1
position exited
Position History SRPT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2020 | 169.3K | $27M | +0.83% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Duquesne Family Office LLC’s full portfolio or all institutional holders of SRPT.